1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 IBS-D Drugs
1.2.3 IBS-C Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2017-2028)
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Region
2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics
2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends
2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue
3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2017-2022)
3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2021
3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
3.6 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
3.7 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type
4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2023-2028)
5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application
5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028)
6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
6.2.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
6.2.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028)
6.2.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2017-2028)
6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
6.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
6.3.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028)
6.3.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2017-2028)
6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
6.4.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022)
6.4.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028)
7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
7.2.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2017-2028)
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
7.3.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2017-2028)
7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
7.4.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
8.2.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
8.3.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region
8.4.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028)
9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
9.2.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2017-2028)
9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
9.3.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2017-2028)
9.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
9.4.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
10.2.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
10.3.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
10.4.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Ironwood Pharmaceuticals Business Overview
11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
11.1.5 Ironwood Pharmaceuticals Recent Developments
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
11.2.5 Bausch Health Recent Developments
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
11.3.5 Takeda Recent Developments
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Details
11.4.2 Sebela Pharmaceuticals Business Overview
11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
11.4.5 Sebela Pharmaceuticals Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
11.5.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of IBS-D Drugs
Table 3. Key Players of IBS-C Drugs
Table 4. Key Players of Others
Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2017-2022)
Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2023-2028)
Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Players (2017-2022)
Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2021)
Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 22. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Application (2017-2022)
Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Application (2023-2028)
Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 62. Ironwood Pharmaceuticals Company Details
Table 63. Ironwood Pharmaceuticals Business Overview
Table 64. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 65. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million)
Table 66. Ironwood Pharmaceuticals Recent Developments
Table 67. Bausch Health Company Details
Table 68. Bausch Health Business Overview
Table 69. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 70. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million)
Table 71. Bausch Health Recent Developments
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 75. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million)
Table 76. Takeda Recent Developments
Table 77. Sebela Pharmaceuticals Company Details
Table 78. Sebela Pharmaceuticals Business Overview
Table 79. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 80. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million)
Table 81. Sebela Pharmaceuticals Recent Developments
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 85. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022) & (US$ Million)
Table 86. Allergan Recent Developments
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2021 VS 2028
Figure 2. IBS-D Drugs Features
Figure 3. IBS-C Drugs Features
Figure 4. Others Features
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2021 VS 2028
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region: 2021 VS 2028
Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2021
Figure 13. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2021
Figure 15. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2028)
Figure 17. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2028)
Figure 18. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Country (2017-2028)
Figure 19. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2028)
Figure 23. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2028)
Figure 24. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Country (2017-2028)
Figure 25. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Region (2017-2028)
Figure 35. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Country (2017-2028)
Figure 45. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Country (2017-2028)
Figure 51. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
Figure 55. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
Figure 56. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
Figure 57. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
Figure 58. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
